キッズウェル・バイオ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4584/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2018/10/19 | 日証協 | 684,776株 | +6.87% | 91,309株 | -61.52% | 922,161株 | +2.74% | 12,500株 | -81.34% |
2018/10/12 | 日証協 | 640,767株 | +34.4% | 237,288株 | +1.1% | 897,552株 | +11.6% | 67,000株 | -44.86% |
2018/10/05 | 日証協 | 476,767株 | -8.8% | 234,700株 | +126.54% | 804,240株 | -2.1% | 121,500株 | +571.27% |
2018/09/28 | 日証協 | 522,767株 | +3.14% | 103,600株 | +51.24% | 821,520株 | +0.2% | 18,100株 | -67.86% |
2018/09/21 | 日証協 | 506,867株 | +10.97% | 68,500株 | -69.34% | 819,840株 | +4.04% | 56,312株 | -28.08% |
2018/09/14 | 日証協 | 456,767株 | +23.97% | 223,430株 | +375.38% | 788,040株 | +5.1% | 78,300株 | +133.73% |
2018/09/07 | 日証協 | 368,437株 | -12.22% | 47,000株 | -81.23% | 749,810株 | -2.93% | 33,500株 | -51.24% |
2018/08/31 | 日証協 | 419,737株 | +3.89% | 250,397株 | -18.1% | 772,410株 | -1.06% | 68,700株 | -52.81% |
2018/08/24 | 日証協 | 404,028株 | +15.21% | 305,745株 | +31.72% | 780,710株 | +6.5% | 145,570株 | +19.81% |
2018/08/17 | 日証協 | 350,700株 | +47.29% | 232,109株 | +69.67% | 733,040株 | +12.1% | 121,500株 | -8.3% |
2018/08/10 | 日証協 | 238,100株 | +36.13% | 136,800株 | +106.96% | 653,940株 | +4.66% | 132,500株 | +323.19% |
2018/08/03 | 日証協 | 174,900株 | +60.46% | 66,100株 | +80.11% | 624,848株 | +8.48% | 31,310株 | -33.38% |
2018/07/27 | 日証協 | 109,000株 | -31.58% | 36,700株 | +9999.99% | 576,000株 | -4.38% | 47,000株 | +1170.27% |
2018/07/20 | 日証協 | 159,300株 | 0% | 300株 | 0% | 602,412株 | 0% | 3,700株 | 0% |
2018/07/13 | 日証協 | 207,600株 | -3.44% | 31,800株 | -68.95% | 622,112株 | +0.19% | 6,900株 | -97.92% |
2018/07/06 | 日証協 | 215,000株 | +57.51% | 102,400株 | +62.27% | 620,950株 | +211.1% | 331,800株 | +361.47% |
2018/06/29 | 日証協 | 136,500株 | +56.9% | 63,106株 | +341.3% | 199,600株 | -33.53% | 71,900株 | +382.55% |
2018/06/22 | 日証協 | 87,000株 | -13% | 14,300株 | -20.11% | 300,268株 | -2.97% | 14,900株 | +27.31% |
2018/06/15 | 日証協 | 100,000株 | -10.63% | 17,900株 | -76.57% | 309,468株 | +0.03% | 11,704株 | -81.1% |
※株式分割は考慮していませんのでご注意ください。
Page Top